Takara Bio Inc. (FRA:TF2)
4.060
-0.060 (-1.46%)
At close: Jan 28, 2026
Takara Bio Revenue
Takara Bio had revenue of 9.53B JPY in the quarter ending September 30, 2025, a decrease of -15.42%. This brings the company's revenue in the last twelve months to 44.08B, down -0.16% year-over-year. In the fiscal year ending March 31, 2025, Takara Bio had annual revenue of 45.04B with 3.53% growth.
Revenue (ttm)
44.08B JPY
Revenue Growth
-0.16%
P/S Ratio
2.10
Revenue / Employee
24.78M JPY
Employees
1,779
Market Cap
533.27M EUR
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 45.04B | 1.53B | 3.53% |
| Mar 31, 2024 | 43.51B | -34.64B | -44.33% |
| Mar 31, 2023 | 78.14B | 10.44B | 15.43% |
| Mar 31, 2022 | 67.70B | 21.61B | 46.90% |
| Mar 31, 2021 | 46.09B | 11.52B | 33.33% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paul Hartmann AG | 2.44B |
| FRoSTA Aktiengesellschaft | 652.00M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |
| Berliner Effektengesellschaft AG | 174.56M |
| Novabase S.G.P.S. | 130.35M |